LISBON, March 5 (Xinhua) -- Scientists have successfully created anti-tumor immune cells in a laboratory using cellular reprogramming for the first time, opening new possibilities in the fight against ...

The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max Planck Institute for Molecular Genetics, Germany, has been named the ...

Scientists are amazed by the warty comb jellyfish, Mnemiopsis leidyi. This sea creature can reverse its life cycle to a juvenile stage when conditions become tough. This ability was previously thought ...

Alexander Meissner’s work has fundamentally advanced our understanding of epigenetic regulation and cellular reprogramming,” said ISSCR President Hideyuki Okano. “Equally important is his dedication ...

A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...

A growing body of research is challenging the long-held assumption that memory and awareness belong exclusively to the brain. Scientists working across immunology, biophysics, and neuroscience have ...

Mediated Microenvironmental Modulation Targeting Osteoclasts for ONFH Niche Reprogramming" has been published in ...

The mechanism for muscle stem cells repair could inspire therapeutics for muscle loss caused by injury, aging and weight-loss medications.

Researchers identified invasive early disseminated cancer cells and immunosuppressive macrophage signaling that promote ...

Dr. Maraganore brings more than three decades of experience leading discovery, development and commercialization of groundbreaking medicines -- Founding CEO of Alnylam Pharmaceuticals led company ...

Scientists reprogrammed two widely used “chemically induced proximity” systems in a recent chemical science paper. CIP systems are very simple: when a small molecule is added, two engineered protein ...

High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...